Literature DB >> 26438567

Celebrating 75 years of oestradiol.

Evan Simpson1, Richard J Santen2.   

Abstract

Oestrogens exert important effects on the reproductive as well as many other organ systems in both men and women. The history of the discovery of oestrogens, the mechanisms of their synthesis, and their therapeutic applications are very important components of the fabric of endocrinology. These aspects provide the rationale for highlighting several key components of this story. Two investigators, Edward Doisy and Alfred Butenandt, purified and crystalized oestrone nearly simultaneously in 1929, and Doisy later discovered oestriol and oestradiol. Butenandt won the Nobel Prize for this work and Doisy's had to await his purification of vitamin K. Early investigators quickly recognized that oestrogens must be synthesized from androgens and later investigators called this process aromatization. The aromatase enzyme was then characterized, its mechanism determined, and its structure identified after successful crystallization. With the development of knock-out methodology, the precise effects of oestrogen in males and females were defined and clinical syndromes of deficiency and excess described. Their discovery ultimately led to the development of oral contraceptives, treatment of menopausal symptoms, therapies for breast cancer, and induction of fertility, among others. The history of the use of oestrogens for postmenopausal women to relieve symptoms has been characterized by cyclic periods of enthusiasm and concern. The individuals involved in these studies, the innovative thinking required, and the detailed understanding made possible by evolving biologic and molecular techniques provide many lessons for current endocrinologists.
© 2015 Society for Endocrinology.

Entities:  

Keywords:  aromatase; oestradiol; oestrogen; regulation

Mesh:

Substances:

Year:  2015        PMID: 26438567     DOI: 10.1530/JME-15-0128

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  27 in total

Review 1.  Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients.

Authors:  Lisa M Wu; Ali Amidi
Journal:  Curr Opin Support Palliat Care       Date:  2017-03       Impact factor: 2.302

Review 2.  Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.

Authors:  Matthias Barton; Edward J Filardo; Stephen J Lolait; Peter Thomas; Marcello Maggiolini; Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-25       Impact factor: 4.292

3.  Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.

Authors:  M Angeles Lillo; Cydney Nichols; Chanel Perry; Stephanie Runke; Raisa Krutilina; Tiffany N Seagroves; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  J Appl Toxicol       Date:  2016-09-01       Impact factor: 3.446

4.  Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells.

Authors:  M Angeles Lillo; Cydney Nichols; Tiffany N Seagroves; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Horm Cancer       Date:  2017-02-27       Impact factor: 3.869

Review 5.  Estrogen and thrombosis: A bench to bedside review.

Authors:  Mouhamed Yazan Abou-Ismail; Divyaswathi Citla Sridhar; Lalitha Nayak
Journal:  Thromb Res       Date:  2020-05-11       Impact factor: 3.944

Review 6.  Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Authors:  M R Holt; J J Miles; W J Inder; R M Thomson
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

7.  Aqueous solution interactions with sex hormone-binding globulin and estradiol: a theoretical investigation.

Authors:  A J da Silva; E S Dos Santos
Journal:  J Biol Phys       Date:  2018-07-05       Impact factor: 1.365

Review 8.  Aromatase expression and regulation in breast and endometrial cancer.

Authors:  Hong Zhao; Ling Zhou; Anna Junjie Shangguan; Serdar E Bulun
Journal:  J Mol Endocrinol       Date:  2016-04-11       Impact factor: 5.098

9.  Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells.

Authors:  Ping Gong; Zeynep Madak-Erdogan; Jodi A Flaws; David J Shapiro; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2016-08-16       Impact factor: 4.102

10.  Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.

Authors:  Pulak R Manna; Ahsen U Ahmed; David Vartak; Deborah Molehin; Kevin Pruitt
Journal:  Biochem Biophys Res Commun       Date:  2018-12-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.